F-CRIN, TOGETHER TO SUPPORT CLINICAL RESEARCH IN FRANCE

Size: px
Start display at page:

Download "F-CRIN, TOGETHER TO SUPPORT CLINICAL RESEARCH IN FRANCE"

Transcription

1 F-CRIN, TOGETHER TO SUPPORT CLINICAL RESEARCH IN FRANCE 1

2 F-CRIN : HOW AND WHY? A national and European challenge to Strengthen the most promising of French Clinical Research to Europe A structure funded by the French government: Investissements d Avenir Call in millions for 8 years A common collaboration with all national partners of the academic clinical research: INSERM, CNCR (National Committee for Research Coordination), Hospitals, Universities A partnership with Healthcare Industries (ARIIS ) 2

3 F-CRIN = a Shared Project A Common Goal The hub for a national access to sponsors and investigators : 1. To support big multicenter academic clinical trials 2. To reinforce the participation and the coordination of European projects by French clinical teams 3. To foster industrial Proof- of-concept studies in innovative therapies Financial Resources 20M 3

4 ACTION PLAN : 5 ITEMS 1. Select platforms and investigational networks able to provide support to innovative projects in France and Europe 2. Propose shared clinical trials procedures to the different academic research partners 3. Help the set up and the management of complex European/international projects 4. Professionalize clinical research jobs through training 5. Be the French component of the ECRIN Network 4

5 1ST GOAL Select Platforms and Investigational Networks able to provide support to innovative projects in France and Europe. 2 Platforms EUCLID (Bordeaux) PARTNERS (Paris) 2 Crossectional facilities ORPHANDEV (rare diseases) TECH4HEALT H (medical devices) 8 INIs Investigators Network Initiative FACT (Cardiovascular) FORCE (Obesity) IMMIDIATE (Auto-immune and Autoinflammatory diseases) INI-CRCT (Cardiovascular and Renal) INNOVTE (Thrombosis) I-REIVAC (Vaccinology) NS-PARK (Parkinson s disease and Movement Disorders) TRIGGERSEP (Sepsis) 5

6 F-CRIN, operational structure providing services to investigators & sponsors to support clinical research projects 6

7 FINANCIAL CONDITIONS TO ACCESS THE SERVICES A same «Price list» for «Platforms/INIs» An access to excellence which has a price An expected return on investment for F-CRIN (in accordance with the of «Inv.d avenir») 7

8 2ND GOAL Propose shared clinical trials procedures to the different academic research partners 2 Workpackages involved : WP3: Coordination of services and portal access WP4: Tools and common procedures (Quality Assurance ; Management, PV ) 8

9 3RD GOAL Help the set up and the management of complex European/international projects Alchemist Sympath 9

10 ONGOING IND.PROJECTS IND. Project EN SponsorCOURS Funding Indication Role of FCRIN POC «BN IPSEN MSA-DOPS Pierre Fabre Innovation CHU Toulouse Pierre Fabre PF/ FCRIN Conception; Support IPSEN + FOX Dyskinésies chez le parkinsonien for management Supervision QA PHRC + Effets du L-ThreoDOPS sur l HO monitoring; Data Chelsea de l AMS management Récupération fonctionnelle. Etude imagerie et sujet sain AFFIRIS 009 AFFIRIS AG (Autriche) POC «NLX-112» Neurolixis FP7 AFFITOPE vaccines, in patient with (MSA) Neurolixis/FOXDyskinésie Parkinson Bumétamide Neurochlore Neurochlore Parkinson Vaccination zona chez les Vaccin Zona/VIH GSK GSK patients VIH SANOFI- Vaccin ClostridiumSanofi-PasteurPASTEUR COUPER Bayer Bayer Cohorte embolie pulmonaire 10 Monitoring, Training, Quality control Conception; support to carry out Conception; Support for management Support for management Support for management Conception; Support for management 10

11 SUPPORT TO EUROPEAN PROJECTS Project Thematic Indication Coordinator NS Park D Devos PHC 13 Mal Rares S de Kramer PHC 5 CRCT P Rossignol Retreat Frail PHC 17 INNOVTE / Symptoms D Parkinson ; chélation FE Protéomique fœtale et valve urétrales post HTA 3 âge institution CHU Lille Inserm Inserm Mottier PHC 13 AC et sujets âgés CHU Brest Chir bariatrique FORCE M Laville PHC 17 sujets âgés CRNH Lyon FACT G Steg PHC 13 IL2 et IdM Inserm INNOVTE / RECIDIVES G Meyer PHC 5 récidive VTE Inserm sepsis âgé en réa TRIGGER SEP PHC 17 Inserm PARTNERS/ K Chevreul mhealth prévention suicide en soins primaires 11

12 4TH GOAL Professionalize clinical research jobs through training F-CRIN initiative European and international projects set -up Train the trainer to clinical research for investigators F-CRIN partnership Methodology for Clinical research in movements disorders with Movement Disorders Society Méthodology For Clinical trials in Rare Diseases with OrphanDev Clinical research and Innovation in the hospital with EHESP 12

13 5TH GOAL As French component of access to the European level, the EuCo EuCo EuCo EuCo EuCo = European Correspondent 13

14 ECRIN-ERIC AND ITS PARTNERS ECRIN ERIC not-for-profit organisation MEMBER Scientific Partners (national networks & hubs) MEMBER EC OBSERVER framework contracts on provision and costs of services quality assurance MEMBER EC Core Team EC NON MEMBER single contract with sponsor third parties PIC AFFILIATE PARTNER AFFILIATE PARTNER Data centres NON MEMBER 14

15 LE PROGRAMME Comité Essais cliniques Europe France 15 15

The Training & Education Unit of F-CRIN's head office. Project manager

The Training & Education Unit of F-CRIN's head office. Project manager Develop and boost training in clinical research Train the actors of clinical research A training course offer built specificaly to answer both the needs of the professionals and the patients: professions,

More information

Ebola - retour d expérience sur la mise en place d essais vaccinaux

Ebola - retour d expérience sur la mise en place d essais vaccinaux De fis Scientifiques et Economiques du De veloppement de Vaccins pour les Pays du Sud 2 & 3 Décembre 2015, Institut Pasteur, Paris Ebola - retour d expérience sur la mise en place d essais vaccinaux Pr

More information

Horizon Introduction. Alex Harris Medical Research Council

Horizon Introduction. Alex Harris Medical Research Council Horizon 2020 - Introduction Alex Harris Medical Research Council Agenda MRC and Horizon 2020 UK Success Rate (FP7 Health) What is Horizon 2020? The Horizon 2020 Health Challenge NCP support MRC and Horizon

More information

Faiez Zannad, MD, PhD, Nancy

Faiez Zannad, MD, PhD, Nancy 1 Biotargets, drug discovery and therapeutic innovation. How French clinical networks can accelerate the discovery of new treatments in the field of cardiovascular and metabolic diseases? Faiez Zannad,

More information

Mental Health. Patrizia Tosetti, PhD Unit F2 Medical Research DG Research and Innovation

Mental Health. Patrizia Tosetti, PhD Unit F2 Medical Research DG Research and Innovation European efforts in Mental Health research Patrizia Tosetti, PhD Unit F2 Medical Research DG Research and Innovation European Commission Conference on Psychotherapy in Europe EP, Brussels 9 February 2012

More information

Brain research supported by the European Union

Brain research supported by the European Union Brain research supported by the European Union Lara Passante, PhD Health Directorate Directorate-General for Research & European Commission FENS Featured Regional Meeting 11-14 Septembre 2013 Prague Neuroscience:

More information

Towards tailored and targeted asthma self-management using mobile technologies

Towards tailored and targeted asthma self-management using mobile technologies Towards tailored and targeted asthma self-management using mobile technologies Funded by the European Union Asthma: the problem Asthma is a lifelong chronic disease caused by inflammation of the airways,

More information

Networking Clinical Trials Anna Shevlin, Clinical Trial Liaison Officer

Networking Clinical Trials Anna Shevlin, Clinical Trial Liaison Officer Networking Clinical Trials Anna Shevlin, Clinical Trial Liaison Officer HRB CRCI International Clinical Trial Networks Networking Clinical Trials Clinical Research Infrastructure Disease Clinical Research

More information

Development of Geriatric Oncology in France

Development of Geriatric Oncology in France Development of Geriatric Oncology in France Pr Pierre Soubeyran Institut Bergonié, Bordeaux, France Epidemiology French population, 2013 9% older than 75 (10.9% females, 7% males) Number of cancer cases

More information

Positioning. > MEMENTO is a large observational study enrolling patients at an. Data first availability for project analyses

Positioning. > MEMENTO is a large observational study enrolling patients at an. Data first availability for project analyses : determinants and Evolution of AlzheiMer s disease and related disorders ITMO Santé publique OVERVIEW AT A GLANCE Bordeaux Geneviève Chêne, MD, PhD Professor of Biostatistics and Public Health, Bordeaux

More information

DEMENTIA: IMPLEMENTATION REPORT AND CURRENT DEVELOPMENTS EU HEALTH

DEMENTIA: IMPLEMENTATION REPORT AND CURRENT DEVELOPMENTS EU HEALTH DEMENTIA: IMPLEMENTATION REPORT AND CURRENT DEVELOPMENTS EU HEALTH Brussels, 19 March 2015 Michael Hübel Programme Management and Diseases Directorate-General for Health and Food Safety European Commission

More information

Council of the European Union Brussels, 28 October 2015 (OR. en)

Council of the European Union Brussels, 28 October 2015 (OR. en) Conseil UE Council of the European Union Brussels, 28 October 2015 (OR. en) PUBLIC 13261/15 LIMITE SAN 347 NOTE From: To: Subject: General Secretariat of the Council Working Party on Public Health Draft

More information

Gesundheit in Horizont 2020

Gesundheit in Horizont 2020 Wien, 5, Dezember 2013 Gesundheit in Horizont 2020 Gesellschaftliche Herausforderung 1: Gesundheit, demografischer Wandel und Wohlergehen Dr Elmar Nimmesgern GD Forschung und Innovation Europäische Kommission

More information

at the University Hospital (CHU) of Besançon

at the University Hospital (CHU) of Besançon CHRU centre hospitalier régional universitaire Research & Innovation at the University Hospital (CHU) of Besançon THINK, INNOVATE, DIFFUSE, SHARE Meeting health challenges for better care Biotherapy module

More information

1. The Working Party on Public Health discussed and agreed the draft Council conclusions as set out in the Annex.

1. The Working Party on Public Health discussed and agreed the draft Council conclusions as set out in the Annex. Council of the European Union Brussels, 26 November 2015 (OR. en) 14395/15 SAN 391 NOTE From: To: Subject: General Secretariat of the Council Permanent Representatives Committee/Council Employment, Social

More information

Future of Diabetes Research in Europe JDRF Perspective

Future of Diabetes Research in Europe JDRF Perspective Future of Diabetes Research in Europe JDRF Perspective IMI-JDRF Diabetes Patient Meeting 20 May 2014 Brussels, Belgium Olivier ARNAUD, Pharm D JDRF European Research Director oarnaud@jdrf.org Future of

More information

Table Of Content. Policy Action and Information for Rare Diseases in Europe... 2 Summary... 3 Coordinator, Leader contact and partners...

Table Of Content. Policy Action and Information for Rare Diseases in Europe... 2 Summary... 3 Coordinator, Leader contact and partners... Table Of Content Policy Action and Information for Rare Diseases in Europe... 2 Summary... 3 Coordinator, Leader contact and partners... 6 Kontaktudvalget for Mindre Sygdoms-og handicapforeninger (KMS)...

More information

Cancer Research in the EU Framework Programmes for RTD

Cancer Research in the EU Framework Programmes for RTD Cancer Research in the EU Framework Programmes for RTD Action against cancer: European platform Maria Vidal, MD, PhD Deputy Head of Unit Medical and public health research Health Directorate DG Research

More information

FP7 PEOPLE PROGRAMME. MARIE CURIE Host - Driven ACTIONS Calls 2012

FP7 PEOPLE PROGRAMME. MARIE CURIE Host - Driven ACTIONS Calls 2012 FP7 PEOPLE PROGRAMME MARIE CURIE Host - Driven ACTIONS Calls 2012 Laura APOSTOL Research Executive Agency (REA) Unit P4, Marie Curie Host-Driven Actions 1 MC Actions FP7 overview (2007-2013) FP7 breakdown

More information

PHOTO. VHPB/ELPA MEETING Prevention and Control of Viral Hepatitis The role and impact of patients and advocacy groups in and outside Europe

PHOTO. VHPB/ELPA MEETING Prevention and Control of Viral Hepatitis The role and impact of patients and advocacy groups in and outside Europe www.eurordis.org VHPB/ELPA MEETING Prevention and Control of Viral Hepatitis The role and impact of patients and advocacy groups in and outside Europe Lucca ( Italy ) March 13-14, 2008 PHOTO www.eurordis.org

More information

What EU research policy can do for conditions such as chronic pain?

What EU research policy can do for conditions such as chronic pain? The EU Framework Programme for Research and Innovation HORIZON 2020 What EU research policy can do for conditions such as chronic pain? K Berkouk, PhD Deputy Head of Unit, Non-communicable diseases and

More information

Workshop on Extrapolation and Evidence Synthesis in the Development and Therapeutic Use of Medicines in Children

Workshop on Extrapolation and Evidence Synthesis in the Development and Therapeutic Use of Medicines in Children Workshop on Extrapolation and Evidence Synthesis in the Development and Therapeutic Use of Medicines in Children Dr Oscar Della Pasqua WP 4 11th June 2013 Strathclyde University, Glasgow, UK Project AIMS

More information

EU Funding for Global Health Research and Development (GH R&D) Cecile Vernant, Head of EU Advocacy, DSW EU 13 June 2014

EU Funding for Global Health Research and Development (GH R&D) Cecile Vernant, Head of EU Advocacy, DSW EU 13 June 2014 EU Funding for Global Health Research and Development (GH R&D) Cecile Vernant, Head of EU Advocacy, DSW EU 13 June 2014 EU Horizon 2020 for 2014-2020 In current prices nearly 80 billion; in constant prices

More information

EVATEL Study. Remote follow-up of patients implanted with an ICD The prospective randomized EVATEL study

EVATEL Study. Remote follow-up of patients implanted with an ICD The prospective randomized EVATEL study EVATEL Study Remote follow-up of patients implanted with an ICD The prospective randomized EVATEL study Philippe Mabo, Pascal Defaye, Nicolas Sadoul, Jean Marc Davy, Jean-Claude Deharo, Salem Kacet, Eric

More information

Cancer prevention and control in the context of an integrated approach

Cancer prevention and control in the context of an integrated approach SEVENTIETH WORLD HEALTH ASSEMBLY A70/A/CONF./9 Agenda item 15.6 25 May 2017 Cancer prevention and control in the context of an integrated approach Draft resolution proposed by Brazil, Canada, Colombia,

More information

Central European Pediatric Oncology Early Trial Alliance. Regina Demlova

Central European Pediatric Oncology Early Trial Alliance. Regina Demlova Central European Pediatric Oncology Early Trial Alliance Regina Demlova CEPOETA A non-profit organization supporting the clinical research in pediatric oncology in CEE region, particularly in the area

More information

R&D UNICANCER Oncology Research

R&D UNICANCER Oncology Research R&D UNICANCER Oncology Research R&D UNICANCER A national academic sponsor dedicated to clinical research in oncology Our missions: Promote and accelerate Clinical Research in Oncology, especially in areas

More information

Personalized medecine Biomarker

Personalized medecine Biomarker Patient Disease Diagnosis Risk prediction Personalized medecine Biomarker Targeted therapies Diagnostic Theranostic: Efficay Toxicity Treatment 1 THE CASE FOR PERSONALIZED MEDICINE IS COMPELLING.. Toxicity

More information

Bordeaux Integrated Oncology Research (BRIO) Part of the French National Cancer Institute (INCa) Integrated Research Sites Network (SIRICs)

Bordeaux Integrated Oncology Research (BRIO) Part of the French National Cancer Institute (INCa) Integrated Research Sites Network (SIRICs) Bordeaux Integrated Oncology Research (BRIO) Part of the French National Cancer Institute (INCa) Integrated Research Sites Network (SIRICs) 1 Labellised between 2011 & 2012 8 Integrated Cancer Research

More information

CRITICAL APPRAISAL OF THE SPINE LITERATURE: THE FUNDAMENTALS FINAL PROGRAMME

CRITICAL APPRAISAL OF THE SPINE LITERATURE: THE FUNDAMENTALS FINAL PROGRAMME CRITICAL APPRAISAL OF THE SPINE LITERATURE: THE FUNDAMENTALS FINAL PROGRAMME QUICK FACTS WHEN: January 11, 2018 WHERE: Institut Franco-Européen de Chiropraxie (IFEC), 72 chemin de la Flambère, 31300 Toulouse,

More information

The Reimagining Health Collaborative 2017: The Church and Mental Health

The Reimagining Health Collaborative 2017: The Church and Mental Health The Reimagining Health Collaborative 2017: The Church and Mental Health Do you or others in your congregation live with mental illness? Does your congregation long to promote mental health and to respond

More information

Future of diabetes research in the EU- the EC perspectives

Future of diabetes research in the EU- the EC perspectives Future of diabetes research in the EU- the EC perspectives Dr Karim Berkouk, Deputy Head of Unit DG for Health Directorate European Commission Overview Challenges in diabetes Research in diabetes at EU

More information

RIC-Mel Network - Network for Research and Clinical Investigation on Melanoma - French national cohort of

RIC-Mel Network - Network for Research and Clinical Investigation on Melanoma - French national cohort of RIC-Mel Network - Network for Research and Clinical Investigation on Melanoma - French national cohort of melanoma patients Head : Pr Dreno Brigitte, INSERM Unité U892 Equipe 2 «Recherche clinique et translationnelle

More information

Counting down to zero

Counting down to zero 12%... 10%... 8%... Counting down to zero Towards a future with underfunded health research? We, as representatives of the undersigned organisations, welcome the current European Commission s proposal

More information

Making dementia a European priority

Making dementia a European priority Making dementia a European priority Glasgow 1 June 2015 Jean Georges, Executive Director Alzheimer Europe 36 associations in 31 countries 2 Paris Declaration Adopted by Annual General Meeting in Paris

More information

ALS ACT (Accelerated Therapeutics)

ALS ACT (Accelerated Therapeutics) ALS ACT (Accelerated Therapeutics) Request for Proposals: Phase II Clinical development of novel, high-potential treatments for people with ALS Release Date 23 October 2015 Letter of intent due: November

More information

The Innovative Medicines Initiative: an engine for therapeutic innovation

The Innovative Medicines Initiative: an engine for therapeutic innovation The Innovative Medicines Initiative: an engine for therapeutic innovation Michel Goldman 26.11.2014 Brussels Bringing health-related life science and technology sectors into IMI2 The pillars of innovation

More information

INI-CRCT (Cardiovascular and Renal Clinical Trialists) Coord: Prof. P. Rossignol, Nancy Inserm 9501 CIC

INI-CRCT (Cardiovascular and Renal Clinical Trialists) Coord: Prof. P. Rossignol, Nancy Inserm 9501 CIC INI-CRCT (Cardiovascular and Renal Clinical Trialists) Coord: Prof. P. Rossignol, Nancy Inserm 9501 CIC CIC-INSERM, CHU de Nancy- Université de Lorraine UMR Inserm U 1116 Heart failure and Hypertension

More information

The Crisis in. Vaccine Development

The Crisis in. Vaccine Development The Crisis in Vaccine Development Stanley A. Plotkin 1 Annecy 2015 The Evolution of the Vaccine Industry 1. 18 th -19 th Centuries Pioneers 2. 1900-1950 National Producers 3. 1960-1980 Globalization 4.

More information

Letter from the CEO. Dear Friends of IAVI,

Letter from the CEO. Dear Friends of IAVI, IAVI Annual Report 2017 Letter from the CEO Dear Friends of IAVI, We are pleased to present an overview of the progress IAVI and partners have made in 2017 toward our pursuit of the development of vaccines

More information

Ageing in Greater Manchester Paul McGarry, Strategic Lead, Public Health Manchester

Ageing in Greater Manchester Paul McGarry, Strategic Lead, Public Health Manchester Ageing in Greater Manchester Paul McGarry, Strategic Lead, Public Health Manchester An age-friendly city is a city that encourages active ageing by optimising opportunities for health, participation and

More information

14414/15 AF/evt 1 DG G 3 C

14414/15 AF/evt 1 DG G 3 C Council of the European Union Brussels, 25 November 2015 (OR. en) 14414/15 RECH 282 COMPET 531 SOC 684 NOTE From: Permanent Representatives Committee (Part 1) To: Council No. prev. doc.: 13902/15 RECH

More information

ANRS CO12 CIRVIR - Prospective cohort involving patients with viral cirrhosis B and C

ANRS CO12 CIRVIR - Prospective cohort involving patients with viral cirrhosis B and C ANRS CO12 CIRVIR - Prospective cohort involving patients with viral cirrhosis B and C Head : Nahon Pierre, Service d'hépatologie, Hôpital Jean Verdier Roudot-thoraval Françoise, Service de santé publique,

More information

Section des Unités de recherche. Evaluation report. Research unit : Hepatitis C Virology. University Paris 5

Section des Unités de recherche. Evaluation report. Research unit : Hepatitis C Virology. University Paris 5 Section des Unités de recherche Evaluation report Research unit : Hepatitis C Virology University Paris 5 February 2009 Section des Unités de recherche Evaluation report Research unit : Hepatitis C Virology

More information

EUCERD Recommendations on Rare Disease European Reference Networks (RD ERNs)

EUCERD Recommendations on Rare Disease European Reference Networks (RD ERNs) EUCERD Recommendations on Rare Disease European Reference Networks (RD ERNs) EUROPEAN REFERENCE NETWORKS FOR RARE DISEASES IN EUROPE: THE CONTEXT The need for European Reference Networks (ERNs) for rare

More information

Article 1: MEDSTARTUP

Article 1: MEDSTARTUP Article 1: MEDSTARTUP MedStartUp is a GALIEN FOUNDATION BUSINESS FRANCE program initiative which aim to allow, encourage and reward new international partnerships between innovative French and North American

More information

Cancer prevention and control in the context of an integrated approach

Cancer prevention and control in the context of an integrated approach SEVENTIETH WORLD HEALTH ASSEMBLY A70/32 Provisional agenda item 15.6 13 April 2017 Cancer prevention and control in the context of an integrated approach Report by the Secretariat 1. In January 2017, the

More information

IMMUNIZATION IN HUMANITARIAN RESPONSE and PARTNER COORDINATION. GAVI Board - 13 June 2017, Geneva

IMMUNIZATION IN HUMANITARIAN RESPONSE and PARTNER COORDINATION. GAVI Board - 13 June 2017, Geneva IMMUNIZATION IN HUMANITARIAN RESPONSE and PARTNER COORDINATION GAVI Board - 13 June 2017, Geneva SCALE OF HUMANITARIAN RESPONSE NEEDS Strengthened HC System Improved financing Cluster Approach HUMANITARIAN

More information

STRATEGIC PLAN

STRATEGIC PLAN STRATEGIC PLAN 2016 2020 Promoting and supporting excellence in research www.immunology.org BSI STRATEGY 2016 2020 EXECUTIVE SUMMARY OUR MISSION Our mission is to promote excellence in immunological research,

More information

Housing First in Lille Vincent MORIVAL, ABEJ Solidarité

Housing First in Lille Vincent MORIVAL, ABEJ Solidarité Housing First in Lille Vincent MORIVAL, ABEJ Solidarité A Government led trial One of the largest trials of the Housing First Model in Europe 4 cities : Paris, Toulouse, Marseille and Lille Led by DIHAL,

More information

CYPRUS PRESIDENCY OF THE COUNCIL OF THE EU

CYPRUS PRESIDENCY OF THE COUNCIL OF THE EU CYPRUS PRESIDENCY OF THE COUNCIL OF THE EU July December 2012 Research Symposium on Digestive and Liver Diseases Brussels, 18 September 2012 Dr Myrto Azina- Chronides Ministry of Health Cyprus Digestive

More information

Taking Time, Risk, and Cost Out of Drug Discovery

Taking Time, Risk, and Cost Out of Drug Discovery Taking Time, Risk, and Cost Out of Drug Discovery Applications of Diffraction Enhanced Imaging to Osteoarthritis Drug Research EnPro-351 Transforming Lives, Inventing the1futu Executive Summary Propose

More information

R&D Status in Romania

R&D Status in Romania R&D Status in Romania Romania Economy is the second largest country in the Central and Eastern Europe (after Poland); it has a population of 22 million people; it benefits from a strategic geographic position;

More information

rare diseases research through National Plans and Strategies

rare diseases research through National Plans and Strategies Recommendations to support rare diseases research through National Plans and Strategies Dr Domenica Taruscio EUROPLAN Coordinator Director of the Italian Centre for Rare Diseases, Italian National Institute

More information

Pain and Palliative care in the European Commission s Framework Programmes. European Commission Research DG Dr. Elengo Manoussaki

Pain and Palliative care in the European Commission s Framework Programmes. European Commission Research DG Dr. Elengo Manoussaki Pain and Palliative care in the European Commission s Framework Programmes European Commission Research DG Dr. Elengo Manoussaki European Parliament resolution on combating cancer in the enlarged EU Calls

More information

Joint Programming in Neurodegenerative Disease Research (JPND)

Joint Programming in Neurodegenerative Disease Research (JPND) Joint Programming in Neurodegenerative Disease Research (JPND) Building Alliances and Collaborations Prof. Philippe Amouyel, MD, PhD JPND Chair France Disclosure CEO of Fondation Plan Alzheimer Conference

More information

1 November, 2013 or earlier

1 November, 2013 or earlier Job Description JOB TITLE REPORTING RELATIONSHIPS COMPANY START DATE Research Fellow/Senior Research Fellow Deputy Director, The George Institute India Programme Head, Global Surgery and Disability Research,

More information

2008 Public Status Report on the Implementation of the European Risk Management Strategy. Executive Summary

2008 Public Status Report on the Implementation of the European Risk Management Strategy. Executive Summary European Medicines Agency London, 17 March 2009 Doc. Ref. EMEA/43556/2009 2008 Status Report on the Implementation of the European Risk Management Strategy Executive Summary The European Risk Management

More information

C A N C É R O P Ô L E L Y O N A U V E R G N E R H Ô N E - A L P E S

C A N C É R O P Ô L E L Y O N A U V E R G N E R H Ô N E - A L P E S Cancer Research Cluster to Facilitate and Structure Oncology Research C A N C É R O P Ô L E L Y O N A U V E R G N E R H Ô N E - A L P E S s P E E D I N G U P P R O G R E S S CANCÉROPÔLE LYON AUVERGNE RHÔNE-ALPES

More information

The Prime Minister s Challenge on Dementia & 2013, G8 Dementia Legacy Making it Happen

The Prime Minister s Challenge on Dementia & 2013, G8 Dementia Legacy Making it Happen The Prime Minister s Challenge on Dementia & 2013, G8 Dementia Legacy Making it Happen 1 Gill Ayling Head of Department of Health, UK The Key Challenges The Dementia Journey 1. The Prime Minister s Challenge

More information

Pandemic Influenza Planning at Kaiser Permanente

Pandemic Influenza Planning at Kaiser Permanente Pandemic Influenza Planning at Kaiser Permanente Skip Skivington, MBA Interim Vice President of Supply Chain Kaiser Foundation Health Plan, Inc. Eric Koscove, MD Emergency Medicine Santa Clara Medical

More information

PIP Framework Information Session 10 April 2018

PIP Framework Information Session 10 April 2018 Pandemic Influenza Preparedness Framework Sharing of influenza viruses & access to vaccines and other benefits PIP Framework Information Session 10 April 2018 PIP Framework Information Session Purpose:

More information

STRATEGIC APPROACH & WORKPLAN 2007

STRATEGIC APPROACH & WORKPLAN 2007 Rare Diseases Europe STRATEGIC APPROACH 2007-2009 & WORKPLAN 2007 Paris, March 2007 www.eurordis.org Contents Our strategic approach 2007 2009 o Eurordis in 2010 o Strategic orientations o Priorities 2007-2009

More information

GOALS, OBJECTIVES, & STRATEGIES

GOALS, OBJECTIVES, & STRATEGIES GOALS, OBJECTIVES, & STRATEGIES HIGH PERFORMING ORGANIZATION Goal 1 Enhance the Bureau for Public Health s ability to function as an effective, efficient and flexible organization. a. Leadership skills

More information

I. Introduction. II. Program Description

I. Introduction. II. Program Description Advanced Post-Graduate Athletic Training Program Division of Sports Medicine Department of Orthopaedic Surgery Department of Athletics, Physical Education and Recreation I. Introduction The Stanford University

More information

Alcohol and Drug Commissioning Framework for Northern Ireland Consultation Questionnaire.

Alcohol and Drug Commissioning Framework for Northern Ireland Consultation Questionnaire. Alcohol and Drug Commissioning Framework for Northern Ireland 2013-16 Consultation Questionnaire. This questionnaire has been designed to help stakeholders respond to the above framework. Written responses

More information

14 December :00 CET

14 December :00 CET Webinar IMI2 Call 13 Assessment of the uniqueness of diabetic cardiomyopathy relative to other forms of heart failure using unbiased pheno-mapping approaches 14 December 2017 15:00 CET Agenda How to use

More information

SensAge. A Network of Networks, Associations and Organisations. addressing the issues of enabling ageing people with

SensAge. A Network of Networks, Associations and Organisations. addressing the issues of enabling ageing people with A Network of Networks, Associations and Organisations addressing the issues of enabling ageing people with sensory disabilities blind/visual impairment, deaf/hearing impairment, and deafblind - to take

More information

EU SUMMIT 2018 Air Pollution & mhealth Prevention and Control of Chronic Respiratory Diseases

EU SUMMIT 2018 Air Pollution & mhealth Prevention and Control of Chronic Respiratory Diseases EU SUMMIT 2018 Air Pollution & mhealth Prevention and Control of Chronic Respiratory Diseases 23 MARCH 2018 Lithuanian Seimas (Parliament) Gedimino Av. 53, Vilnius, Lithuania Organizers: Endorsed by EU

More information

Strengthening efforts to improve access to and affordability of medicines and technologies in the prevention and control of NCDs

Strengthening efforts to improve access to and affordability of medicines and technologies in the prevention and control of NCDs Strengthening efforts to improve access to and affordability of medicines and technologies in the prevention and control of NCDs Overview and summary of feedback 18-19 February 2015 Summary (from policy

More information

Improving assessment process of health technologies: Towards a MCDA approach?

Improving assessment process of health technologies: Towards a MCDA approach? Improving assessment process of health technologies: Towards a MCDA approach? François Meyer MD Advisor to the President, International Affairs ISPOR Amsterdam November 2014 Assessment of clinical added

More information

A Youth Sector Summary of the Civil Society Strategy. Youth Work Youth Participation Funding for Young People NCS

A Youth Sector Summary of the Civil Society Strategy. Youth Work Youth Participation Funding for Young People NCS A Youth Sector Summary of the Civil Society Strategy Youth Work Youth Participation Funding for Young People NCS Youth Work (Pages 41-42) The government is committed to making sure all young people have

More information

DESIGNED TO TACKLE RENAL DISEASE IN WALES DRAFT 2 nd STRATEGIC FRAMEWORK for

DESIGNED TO TACKLE RENAL DISEASE IN WALES DRAFT 2 nd STRATEGIC FRAMEWORK for DESIGNED TO TACKLE RENAL DISEASE IN WALES DRAFT 2 nd STRATEGIC FRAMEWORK for 2008-11 1. Aims, Outcomes and Outputs The National Service Framework Designed to Tackle Renal Disease in Wales sets standards

More information

Research in viral hepatitis: the French ANRS experience

Research in viral hepatitis: the French ANRS experience PARIS HEPATITIS CONFERENCE January 14-15, 2013 Research in viral hepatitis: the French ANRS experience Pr. Jean-François DELFRAISSY Director of ANRS Internal Medicine Department CHU Bicêtre Paris XI -

More information

Joint Programming Initiative on Neurodegenerative Diseases. Prof. Philippe Amouyel Chair, JPND Management Board

Joint Programming Initiative on Neurodegenerative Diseases. Prof. Philippe Amouyel Chair, JPND Management Board Joint Programming Initiative on Neurodegenerative Diseases Prof. Philippe Amouyel Chair, JPND Management Board Cases / 100 Alzheimer s disease in Europe 40 Number of cases Societal costs ( ) 2010 6,000,000

More information

Base Anatomo Clinique de l Adénocarcinome Pancréatique

Base Anatomo Clinique de l Adénocarcinome Pancréatique Base Anatomo Clinique de l Adénocarcinome Pancréatique Coordinator Dr BOURNET Barbara Project Manager Cindy Canivet Service de Gastroentérologie et Nutrition CHU de Toulouse Aims of BACAP Incidence rate

More information

EXCELLENCE AND INNOVATION

EXCELLENCE AND INNOVATION EXCELLENCE AND INNOVATION FOR CANCER TREATMENT THE CENTRE LÉON BÉRARD Non-profit private health care facility of public interest (ESPIC), affiliated with the French National Cancer Center Federation UNICANCER

More information

The EU strategy in Horizon2020 to fight poverty related diseases

The EU strategy in Horizon2020 to fight poverty related diseases Meeting on EDCTP2 French Ministry of Education, Science and Innovation, Paris 30 June 2017 The EU strategy in Horizon2020 to fight poverty related diseases Line Matthiessen Acting Director Health Directorate

More information

Collaborations in more than 50 countries. 400 scientific papers published every year. Over 800 professionals trained every year

Collaborations in more than 50 countries. 400 scientific papers published every year. Over 800 professionals trained every year Antoni Plasència General Director In an interdependent world, health is a global issue. Our commitment to improving the health of all people and ensuring greater equity is implemented through the generation,

More information

Novo Nordisk Pharma AG Methodology Note - reporting year 2016 ( Methodology )

Novo Nordisk Pharma AG Methodology Note - reporting year 2016 ( Methodology ) Novo Nordisk Pharma AG Methodology Note - reporting year 2016 ( Methodology ) Table of contents Preamble... 0 1. General Summary... 1 2. Terminology and Definitions... 2 3. Change log... 8 Preamble Novo

More information

The Global Network Aiming to deliver safe quality care in relation to tobacco for every service user, every time and everywhere

The Global Network Aiming to deliver safe quality care in relation to tobacco for every service user, every time and everywhere The Global Network Aiming to deliver safe quality care in relation to tobacco for every service user, every time and everywhere STRATEGIC PLAN 2015 2018 Use of Terms For the purpose of Global Network the

More information

3.1 Publishable summary

3.1 Publishable summary 3.1 Publishable summary PROJECT CONTEXT AND OBJECTIVES Type 2 diabetes, formerly known as non insulin dependent diabetes (NIDDM), is one of the fastest growing chronic diseases worldwide. This is primarily

More information

The French National Rare Diseases Registries BNDMR-BaMaRa and RaDiCo

The French National Rare Diseases Registries BNDMR-BaMaRa and RaDiCo The French National Rare Diseases Registries BNDMR-BaMaRa and RaDiCo Pr Paul Landais Montpellier 1 University, EA 2415, Faculty of Medecine Nîmes University Hospital, France National Databank for RaRe

More information

The European Framework Program for Research & Innovation: Horizon 2020: Health, demographic change & wellbeing

The European Framework Program for Research & Innovation: Horizon 2020: Health, demographic change & wellbeing The European Framework Program for Research & Innovation: Horizon 2020: Health, demographic change & wellbeing Sasha Hugentobler National Contact Point Health Euresearch Head Office phone +41 31 380 60

More information

Steady Ready Go! teady Ready Go. Every day, young people aged years become infected with. Preventing HIV/AIDS in young people

Steady Ready Go! teady Ready Go. Every day, young people aged years become infected with. Preventing HIV/AIDS in young people teady Ready Go y Ready Preventing HIV/AIDS in young people Go Steady Ready Go! Evidence from developing countries on what works A summary of the WHO Technical Report Series No 938 Every day, 5 000 young

More information

Global strategy on viral hepatitis and regional action plan: monitoring framework and 10 core indicators

Global strategy on viral hepatitis and regional action plan: monitoring framework and 10 core indicators Global strategy on viral hepatitis and regional action plan: monitoring framework and 10 core indicators Antons Mozalevskis WHO Regional Office for Europe EMCDDA DRID National Expert Meeting Lisbon, 6

More information

Rare Cancer Perspective in the EUCERD

Rare Cancer Perspective in the EUCERD EURORDIS' activities on EU and National Policies Rare Cancer Perspective in the EUCERD Jan Geissler Alternate Member, EU Committee of Experts for Rare Diseases (EUCERD) Director, European Patients Academy

More information

EU safeguards contribution to the global nuclear non-proliferation regime. Safeguards implementation in the European Union

EU safeguards contribution to the global nuclear non-proliferation regime. Safeguards implementation in the European Union 2015 Review Conference of the Parties to the Treaty on the Non-Proliferation of Nuclear Weapons 5 May 2015 NPT/CONF.2015/WP.55. Original: English New York, 27 April-22 May 2015 EU safeguards contribution

More information

Moving towards 2020 priorities for Public Health for the years Health and Consumers

Moving towards 2020 priorities for Public Health for the years Health and Consumers Moving towards 2020 priorities for Public Health for the years 2013-20 Health in the MFF 2014-2020 Commission proposal for the Health for Growth Programme 2014-2020 http://ec.europa.eu/health/programme/policy/index_en.htm

More information

NIH FY 2017 Budget Roll-Out Francis S. Collins, M.D., Ph.D. Director, National Institutes of Health February 9, 2016

NIH FY 2017 Budget Roll-Out Francis S. Collins, M.D., Ph.D. Director, National Institutes of Health February 9, 2016 NIH FY 2017 Budget Roll-Out Francis S. Collins, M.D., Ph.D. Director, National Institutes of Health February 9, 2016 NIH s FY 2017 Budget Request Year FY 2015 FY 2016 FY 2017 Request Program Level ($B)

More information

Involving research participants in research: The example of the EPAD (European Prevention of Alzheimer s Dementia) project

Involving research participants in research: The example of the EPAD (European Prevention of Alzheimer s Dementia) project Involving research participants in research: The example of the EPAD (European Prevention of Alzheimer s Dementia) project Stina Saunders Alzheimer Europe Annual Conference Barcelona 2018 @stina_saunders

More information

EFPT Recommendations On Standards of Psychiatric Training

EFPT Recommendations On Standards of Psychiatric Training 2013 EFPT Recommendations On Standards of Psychiatric Training P a g e 1 FOREWORD The European Federation of Psychiatric Trainees (EFPT) is an independent federation representing 38 psychiatric trainee

More information

Meeting with EMA: cooperation in the field of ERNs. Enrique Terol DG SANTE European Commission

Meeting with EMA: cooperation in the field of ERNs. Enrique Terol DG SANTE European Commission Meeting with EMA: cooperation in the field of ERNs Enrique Terol DG SANTE European Commission London 16 May 2017 The road to European Reference Networks (ERNs) Imagine if the best specialists from across

More information

BDA IMPROVING ONCOLOGY DRUG DEVELOPMENT FOR CHILDREN AND ADOLESCENTS NOVEMBER 2013 WORKSHOP ADVANCE PROGRAMME

BDA IMPROVING ONCOLOGY DRUG DEVELOPMENT FOR CHILDREN AND ADOLESCENTS NOVEMBER 2013 WORKSHOP ADVANCE PROGRAMME BDA WORKSHOP IMPROVING ONCOLOGY DRUG DEVELOPMENT FOR CHILDREN AND ADOLESCENTS 18-19 NOVEMBER 2013 PARIS, FRANCE BIOTHERAPY DEVELOPMENT ASSOCIATION encca European Network for Cancer Research in Children

More information

Protecting the unborn baby from alcohol. Brief Summary

Protecting the unborn baby from alcohol. Brief Summary Protecting the unborn baby from alcohol 17 th September 2013 European Parliament, Brussels Brief Summary October 2013 Organised by: Hosted by: With the support of: 17 Rue Archimede I 1000 Brussels I Belgium

More information

The 2003 Council Recommendation on Cancer Screening and the European Initiative on Breast Cancer

The 2003 Council Recommendation on Cancer Screening and the European Initiative on Breast Cancer The 2003 Council Recommendation on Cancer Screening and the European Initiative on Breast Cancer Conference "Putting Science into Standards" Ispra 20-21 October 2015 Michael Hübel, Head of Unit - Programme

More information

Anti-Infective Clinical Trials

Anti-Infective Clinical Trials Anti-Infective Clinical Trials The extensive clinical training and experience of our infectious disease staff places us in a unique position to fully appreciate the requirements of our clients conducting

More information

European actions in the field of transplantation & blood transfusion

European actions in the field of transplantation & blood transfusion European actions in the field of transplantation & blood transfusion Andrzej Rys Director Directorate Health Systems and Products Madrid, 27 June 2013 1 Blood Tissues and cells Organs 2 Blood transfusion

More information

THE MICHAEL J. FOX FOUNDATION FOR PARKINSON S RESEARCH. Funding Opportunities

THE MICHAEL J. FOX FOUNDATION FOR PARKINSON S RESEARCH. Funding Opportunities THE MICHAEL J. FOX FOUNDATION FOR PARKINSON S RESEARCH Funding Opportunities AGENDA 1. Brief Overview of MJFF Philosophy 2. MJFF Funding Programs 3. How to apply 4. What happens next? 5. Q&A Please feel

More information